MDK and non-small cell lung carcinoma: MDK has also been demonstrated to promote metastasis in vivo. In non-small-cell lung cancer, MDK knockdown abrogated lung metastases in vivo, while increasing MDK promoted a ninefold increase in metastatic burden [93].